The latest closing stock price for Grace Therapeutics as of November 20, 2024 is 3.28.
An investor who bought $1,000 worth of Grace Therapeutics stock at the IPO in 2012 would have $-994 today, roughly -1 times their original investment - a -32.85% compound annual growth rate over 13 years.
The all-time high Grace Therapeutics stock closing price was 1953.60 on August 05, 2013.
The Grace Therapeutics 52-week high stock price is 3.60, which is 9.8% above the current share price.
The Grace Therapeutics 52-week low stock price is 1.98, which is 39.6% below the current share price.
The average Grace Therapeutics stock price for the last 52 weeks is 2.86.
An investor who bought $1,000 worth of Grace Therapeutics stock at the IPO in 2012 would have $-994 today, roughly -1 times their original investment - a -32.85% compound annual growth rate over 13 years.
The all-time high Grace Therapeutics stock closing price was 1953.60 on August 05, 2013.
The Grace Therapeutics 52-week high stock price is 3.60, which is 9.8% above the current share price.
The Grace Therapeutics 52-week low stock price is 1.98, which is 39.6% below the current share price.
The average Grace Therapeutics stock price for the last 52 weeks is 2.86.